Search the Newsreel

NNOX DEADLINE - FINAL REMINDER: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Nano-X Imaging Ltd. to Contact the Firm Today!

Bronstein, Gewirtz & Grossman, LLC is issuing a final reminder to stockholders of Nano-X Imaging Ltd. (NASDAQ:NNOX) about a class action lawsuit. The lawsuit alleges that Nano-X Imaging Ltd. and its officers made false and misleading statements regarding the company's operations and prospects between …

NANO Nuclear to Report Q3 Earnings: Buy, Hold or Sell the Stock?

NANO Nuclear Energy Inc. (NNE) is set to release its fiscal third-quarter results, with the Zacks Consensus Estimate projecting a loss of 28 cents per share. Despite a history of beating earnings estimates, the Zacks Model does not predict an earnings beat this quarter …

NNOX Shareholder Alert: Nano-X Imaging Ltd. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm

The Gross Law Firm has issued a shareholder alert for Nano-X Imaging Ltd. (NASDAQ: NNOX) investors, announcing a securities class action lawsuit. The lawsuit alleges that Nano-X Imaging Ltd. made materially false and misleading statements regarding its operational efficiency and product demand, leading to …

Portnoy Law Firm Announces Class Action on Behalf of Nano-X Imaging Ltd. Investors

The Portnoy Law Firm has announced a class action lawsuit on behalf of investors in Nano-X Imaging Ltd. (NASDAQ: NNOX) who purchased securities between March 31, 2025, and April 17, 2026. The lawsuit alleges that Nano-X overstated its efficiency, experienced misalignment between production and …

Nano-X Imaging (NNOX) CEO Erez Meltzer adds 9,443 shares via owned company

Nano-X Imaging Ltd. CEO Erez Meltzer indirectly purchased 9,443 Ordinary Shares on August 10, 2026, at $1.03 per share through his wholly-owned company, Oud Nof. This transaction increased Oud Nof's holdings to 45,443 shares, while Meltzer also directly holds 60,584 Ordinary Shares and multiple …

Nuclear Energy Stocks Retail Investors Are Watching For AI Power Demand

Urgent Deadline for Shareholders who lost money in shares of Nano-X Imaging Ltd. (NASDAQ: NNOX)

Wolf Haldenstein Adler Freeman & Herz LLP reminds investors of Nano-X Imaging Ltd. (NASDAQ: NNOX) of a class action lawsuit with a lead plaintiff deadline of today, August 11, 2026. The lawsuit alleges that Nano-X overstated its operational efficiency and product demand, leading to …

NANO Nuclear Energy Inc. expected to post a loss of 26 cents a share - Earnings Preview

NANO Nuclear Energy Inc. is projected to report a loss of 26 cents per share, according to this earnings preview. The article, sourced from Reuters via TradingView News, provides this key financial expectation. To access the full details, readers are directed to subscribe for …

Bionano Genomics Inc (BNGO) (Q2 2026) Earnings Call Highlights: Record Flow Cell Sales and ...

Bionano Genomics Inc (BNGO) reported Q2 2026 revenue of $8.2 million, a 21% year-over-year increase, exceeding guidance, driven by record flow cell sales. Despite strong demand and increased gross margins, the company faces supply constraints for flow cells and a decline in software revenue. …

Bionano Genomics, Inc. Q2 2026 Earnings Call Summary

Bionano Genomics, Inc. Q2 2026 Earnings Call Summary - Moby Strategic Execution and Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap …

Bionano Genomics earnings beat by $0.13, revenue topped estimates

Bionano outlines $31M-$33M 2026 revenue forecast amid flow cell supply constraints

Earnings Call Insights: Bionano Genomics (BNGO) Q2 2026 MANAGEMENT VIEW * "Bionano had a strong second quarter, and that strength can be directly attributed to increased adoption by our customers," said (Chairman, Interim CEO, Interim President & Interim Principal Financial Officer Albert Luderer), adding …

Is Bionano Genomics Inc (BNGO) Undervalued After Q2 Earnings? EPS: -$7.4M, Revenue: $8.2M, GF Score: 64/100

Earnings call transcript: Bionano Genomics tops Q2 revenue view, shares edge up

Bionano Genomics (NASDAQ: BNGO) grows revenue amid going concern warning

Bionano Genomics presenta sus previsiones de ingresos para el tercer trimestre y el ejercicio 2026

Bionano Genomics, Inc. Q2 2026: Revenue $8.17M, EPS $(0.64) — 10-Q Summary

Bionano Genomics, Inc. reported its Q2 2026 financial results, showing a 21% increase in revenue to $8.17M, up from $6.73M in Q2 2025. Despite this growth, the company recorded a net loss of $7.42M, though the diluted EPS improved significantly from $(1.99) to $(0.64) …

Bionano Reports Second Quarter 2026 Results and Provides a Business Update

Bionano has reported its second-quarter 2026 financial results, which include updates on its operational performance and strategic initiatives. The company also provided a comprehensive business update detailing its progress and future outlook.

Does NANO Nuclear Energy (NNE) Winning an AFWERX SBIR Deal Validate Its Microreactor Strategy?

NANO Nuclear Energy secured an AFWERX SBIR Phase I contract for its KRONOS MMR™ Energy System, signaling early government interest in its microreactor technology for defense applications. This award, while positive, does not immediately alter the company's core investment narrative, which remains focused on …

Constellation Energy Stock And 2 Nuclear Picks for Reliable Carbon Free Power

NNOX Investors Have Opportunity to Lead Nano-X Imaging Ltd. Securities Fraud Lawsuit with SBS Law

LOS ANGELES, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Nano-X Imaging Ltd. (“Nano-X” or “the Company”) (NASDAQ: NNOX) for violations of §§10(b) and 20(a) of …

NNOX EQUITY ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Nano-X Imaging (NNOX) Investors of Securities Class Action Lawsuit Deadline on August 11, 2026

Faruqi & Faruqi, LLP is reminding investors of Nano-X Imaging (NNOX) about a securities class action lawsuit deadline on August 11, 2026. The lawsuit alleges that Nano-X made false and misleading statements regarding its operational efficiency, product demand, and financial health, leading to increased …

Nanox.AI Optimizes Medical Imaging AI Application Framework for Intel Core Ultra Processors with OpenVINO

On-premise medical imaging AI framework uses Intel Core Ultra processors and Intel’s OpenVINO toolkit to accelerate edge inference within healthcare environments PETACH TIKVA, Israel – August 10 – Nanox AI Ltd., a subsidiary of Nano-X Imaging Ltd. (NASDAQ: NNOX), today announced the optimization of …

Bionano Genomics (BNGO) Earnings Date and Reports 2026

Nano-X Deadline: NNOX Investors Have Opportunity to Lead Nano-X Imaging Ltd. Securities Fraud Lawsuit

Rosen Law Firm is reminding investors of Nano-X Imaging Ltd. (NASDAQ: NNOX) who purchased securities between March 31, 2025, and April 17, 2026, about the August 11, 2026, lead plaintiff deadline for a securities fraud lawsuit. The lawsuit alleges that Nano-X made false and …

Nano Dimension(NNDM) Stock Options Chain | Quotes & News

This article provides access to the stock options chain for Nano Dimension (NNDM), including quotes and news. It serves as a resource for investors interested in NNDM's options trading data.

NNOX Investors Have Opportunity to Lead Nano-X Imaging Ltd. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!

Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Nano-X Imaging Ltd. (NASDAQ:NNOX) on behalf of investors who purchased securities between March 31, 2025, and April 17, 2026. The lawsuit alleges that Nano-X made materially false and misleading statements regarding its …

Nano-X Imaging Raises $8 Million in Registered Direct Offering Completed on August 7, 2026

Nano-X Imaging (NNOX) announced the completion of an $8 million registered direct offering on August 7, 2026, to a single institutional investor. The company issued 8 million ordinary shares or pre-funded warrants along with 8 million purchase warrants, with proceeds intended for working capital …

Bionano Genomics Inc (BNGO) Earnings Forecast: Future EPS & Revenue Growth Estimates

Bionano Genomics | 8-K: Current report

This article is a current report (8-K filing) from Bionano Genomics. It provides links to two separate documents for more details. The content explicitly states that it is for informational and educational purposes only and does not constitute investment advice.

Only 2 of These 5 Nuclear Stocks Sell Fuel Today. Here's What the Market Pays for the Other 3.

Key Points Cameco and Centrus Energy sell nuclear fuel today, with trailing-12-month revenue of about $2.5 billion and $474 million, respectively. Oklo, NuScale Power, and Nano Nuclear Energy carry a combined market value of about $12 billion on roughly $12 million in combined trailing …

NANO Nuclear Energy (NASDAQ:NNE) up 18% after Q3 highlights cash position, first revenue milestone

NANO Nuclear Energy (NASDAQ:NNE) shares rose 18% after its Q3 report highlighted a strong cash position and its first revenue milestone. The company reported $568.7 million in liquidity as of March 31, representing 58.4% of its market value, and interest income that surpassed operating …

Nano Dimension Ltd. Q2 2026: Revenue $28.96M, Net loss $(6.80M) — 10-Q Summary

Nano Dimension Ltd. reported Q2 2026 financial results, showing revenue of $28.96 million, a 12% increase year-over-year, and a net loss of $(6.80) million, a significant improvement from the previous year's loss. The company's revenue growth was driven by product sales and recent acquisitions …

Noticias de acciones de Bionano Genomics Inc (BNGO)

Nano Labs Ltd (NA) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Nano Labs Ltd (NA), focusing on future EPS and revenue growth estimates. It includes a snapshot of the company's current stock performance, market capitalization, and a comparison with peers in the Semiconductors & Semiconductor Equipment sector, such …

BioNano Genomics Inc (0A4K) Q1 2026 Earnings Report - Results, Call & Slides

BioNano Genomics Inc. (0A4K) reported its Q1 2026 earnings, beating analyst expectations with an EPS of -$0.76 against a consensus of -$0.88 and revenue of $6.69M, surpassing the expected $6.57M. The company highlighted positive operational developments including record flow cell sales, strong consumables growth, …